Wegovy's 90-Second Super Bowl 2025 Ad Reveals a Game-Changing Pill

Wegovy's 90-Second Super Bowl 2025 Ad Reveals a Game-Changing Pill

Emily Haynes
Emily Haynes•
• 2 Min.
An old advertisement for Dr. Brooke's Oriental Pills, featuring bold text and a circular logo with a white background and blue border.

Wegovy's 90-Second Super Bowl 2025 Ad Reveals a Game-Changing Pill

Novo Nordisk is set to unveil a 90-second Super Bowl 2025 commercial for Wegovy, its popular weight-loss drug. For the first time, the company will promote the medication as an oral tablet rather than an injection. The advert aims to spark discussions about weight and health during one of the year's most-watched events.

The ad features a high-profile cast, including Kenan Thompson, DJ Khaled, and Serena Williams in a separate campaign by telehealth provider Ro. With multiple weight-loss brands competing for attention, the Super Bowl will highlight the booming demand for these treatments.

The commercial kicks off with Kenan Thompson declaring, 'Big news, America! Wegovy now comes in a pill.' This shift from injectable to oral format could make the drug more appealing to consumers. Novo Nordisk's decision to run a lengthy 90-second spot reflects two key factors: the need to list potential side effects and the inclusion of a diverse cast.

Alongside Thompson, the ad stars DJ Khaled, Danielle Brooks, Ana Gasteyer, John C. Reilly, and Danny Trejo. Their involvement underscores the brand's push for broad representation. Meanwhile, the weight-loss drug market is heating up, with at least three telehealth providers—Ro, Hims & Hers, and Eli Lilly—also advertising GLP-1 medications during the game.

Ro's campaign features Serena Williams and focuses on healthcare affordability. Hims & Hers, another competitor, will promote its own weight-loss solutions. With multiple brands vying for consumer attention, the Super Bowl has become a battleground for the expanding obesity-treatment industry.

The event takes place on February 8, 2026, offering these companies a prime opportunity to reach millions of viewers. Novo Nordisk's emphasis on Wegovy's new pill form suggests confidence in its market potential.

The Super Bowl commercial marks a strategic move for Novo Nordisk, introducing Wegovy as a pill to a wide audience. The 90-second slot ensures compliance with advertising regulations while showcasing its star-studded cast. As telehealth rivals and pharmaceutical giants flood the airwaves, the game will highlight the fierce competition in the weight-loss drug sector.